| Date | Time | Source | Headline | Symbol | Company |
| 11/24/2009 | 9:00AM | Business Wire | Gilead and GlaxoSmithKline Announce Agreement to Commercialize Viread® for Chronic Hepatitis B in Key Asian Countries | NASDAQ:GILD | Gilead Sciences Inc |
| 11/18/2009 | 7:01AM | Marketwired | Fundamental and Technical Research for SFD, RHI, PFG, PDLI, GILD and FUQI Posted on BenchmarkJournal.com Today | NASDAQ:GILD | Gilead Sciences Inc |
| 11/17/2009 | 1:31PM | Edgar (US Regulatory) | Confidential Treatment Order (CT ORDER) | NASDAQ:GILD | Gilead Sciences Inc |
| 11/16/2009 | 8:03PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 11/12/2009 | 8:24PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 11/11/2009 | 4:30PM | Business Wire | Gilead Sciences to Present at the Lazard Capital Markets 6TH Annual Healthcare Conference on Tuesday, November 17 | NASDAQ:GILD | Gilead Sciences Inc |
| 11/10/2009 | 6:04AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:GILD | Gilead Sciences Inc |
| 11/09/2009 | 8:01PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 11/09/2009 | 6:52AM | Marketwired | RidgewaterEquity.com Free Fundamental Sector & Market Research on NETC, MVIS, NCOC, GILD, ROVI and IMMU | NASDAQ:GILD | Gilead Sciences Inc |
| 11/06/2009 | 6:21PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 11/04/2009 | 5:21PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 11/04/2009 | 4:30PM | Business Wire | Gilead Sciences to Present at the 18th Annual Credit Suisse Healthcare Conference on Wednesday, November 11 | NASDAQ:GILD | Gilead Sciences Inc |
| 11/02/2009 | 6:42PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 11/02/2009 | 8:30AM | Business Wire | Gilead Sciences Announces Plans for Phase IV Clinical Trial Evaluating First-Line Combination Therapy Versus Monotherapy in P... | NASDAQ:GILD | Gilead Sciences Inc |
| 10/31/2009 | 5:30PM | Business Wire | Gilead Announces Long-Term Data from Two Pivotal Phase III Studies Evaluating Viread® For Chronic Hepatitis B | NASDAQ:GILD | Gilead Sciences Inc |
| 10/30/2009 | 4:30PM | Business Wire | Gilead Sciences to Present at the Oppenheimer 20th Annual Healthcare Conference on Tuesday, November 3 | NASDAQ:GILD | Gilead Sciences Inc |
| 10/29/2009 | 6:15AM | Marketwired | WallStSense.com Fundamental & Technical Coverage of LJPC, MLHR, GILD, DSCO, HYTM and FISV | NASDAQ:GILD | Gilead Sciences Inc |
| 10/26/2009 | 8:16AM | Business Wire | Gilead’s Aztreonam for Inhalation Solution to be Reviewed by FDA Anti-Infective Drugs Advisory Committee on December 10, 2009 | NASDAQ:GILD | Gilead Sciences Inc |
| 10/20/2009 | 6:34PM | Dow Jones News | 2nd UPDATE: Gilead 3Q Net Rises 36%; Benefits From Tamiflu | NASDAQ:GILD | Gilead Sciences Inc |
| 10/20/2009 | 6:01PM | Dow Jones News | UPDATE: Gilead 3Q Net Rises 36%; Benefits From Tamiflu | NASDAQ:GILD | Gilead Sciences Inc |
| 10/20/2009 | 5:48PM | Dow Jones News | US EARNINGS WRAP: Yahoo, Sallie Mae Smash Profit Views | NASDAQ:GILD | Gilead Sciences Inc |
| 10/20/2009 | 4:55PM | Dow Jones News | Gilead 3Q Profit Rises 36% On Sales Growth, Results Beat Views | NASDAQ:GILD | Gilead Sciences Inc |
| 10/20/2009 | 4:16PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:GILD | Gilead Sciences Inc |
| 10/20/2009 | 4:05PM | Business Wire | Gilead Sciences Announces Record Third Quarter 2009 Financial Results | NASDAQ:GILD | Gilead Sciences Inc |
| 10/20/2009 | 7:24AM | Marketwired | RothmanResearch.com Stock Review for DTV, IMMU, FLIR, GILD, RINO and DSCO | NASDAQ:GILD | Gilead Sciences Inc |
| 10/19/2009 | 9:31AM | PR Newswire (US) | Seven Summits Research Releases Comments on Microsoft, Amazon.com, Celgene, Starwood Hotels and Gilead Sciences | NASDAQ:GILD | |
| 10/16/2009 | 2:55PM | Dow Jones News | US EQUITIES WEEK AHEAD: More 3Q Results; Windows 7 Launches | NASDAQ:GILD | Gilead Sciences Inc. |
| 10/14/2009 | 8:20PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 10/14/2009 | 11:06AM | PR Newswire (US) | Weekly Digest's Investor Essentials Special Report Identifies Unique Investing Opportunities in the H1N1 'Swine Flu' Outbreak | NASDAQ:GILD | Gilead Sciences Inc |
| 10/13/2009 | 4:30PM | Business Wire | Gilead Sciences to Release Third Quarter 2009 Financial Results on Tuesday, October 20, 2009 | NASDAQ:GILD | Gilead Sciences Inc |